Zions Bancorporation N.A. Purchases 4,234 Shares of Integer Holdings Co. (NYSE:ITGR)

Zions Bancorporation N.A. grew its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 19.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,318 shares of the medical equipment provider's stock after buying an additional 4,234 shares during the period. Zions Bancorporation N.A. owned approximately 0.08% of Integer worth $3,421,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ITGR. Contravisory Investment Management Inc. grew its stake in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 80 shares during the period. Xponance Inc. grew its position in Integer by 4.9% during the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock worth $245,000 after acquiring an additional 99 shares during the last quarter. Azzad Asset Management Inc. ADV grew its position in Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock worth $1,504,000 after acquiring an additional 107 shares during the last quarter. GAMMA Investing LLC grew its position in Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after acquiring an additional 142 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in Integer by 3.6% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider's stock worth $689,000 after acquiring an additional 205 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

NYSE:ITGR traded down $2.73 during mid-day trading on Thursday, hitting $134.83. The stock had a trading volume of 225,708 shares, compared to its average volume of 310,767. Integer Holdings Co. has a twelve month low of $84.75 and a twelve month high of $140.91. The stock has a market cap of $4.52 billion, a price-to-earnings ratio of 42.15, a PEG ratio of 1.97 and a beta of 1.09. The company's 50 day simple moving average is $129.02 and its 200 day simple moving average is $122.37. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $1.27 earnings per share. On average, equities research analysts forecast that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Analyst Ratings Changes

ITGR has been the topic of a number of recent research reports. Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a research report on Monday, October 21st. Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, October 1st. Citigroup increased their price objective on Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Tuesday, October 1st. Piper Sandler reiterated an "overweight" rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Finally, KeyCorp increased their price objective on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Integer currently has a consensus rating of "Moderate Buy" and an average target price of $139.75.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.